GWM
AXTA icon

Geneos Wealth Management’s Axalta AXTA Stock Holding History

Geneos Wealth Management’s Portfolio AXTA Stock Details AXTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-446
Closed -$13.2K – 2539
2025
Q2 		$13.2K Sell
446
-4
-0.9% -$125 ﹤0.01% 2213
2025
Q1 		$14.9K Buy
450
+362
+411% +$12.9K ﹤0.01% 2077
2024
Q4 		$3.01K Hold
88
– – ﹤0.01% 2484
2024
Q3 		$3.19K Buy
+88
New +$3.09K ﹤0.01% 2187
2021
Q2 		– Sell
-945
Closed -$30K – 2865
2021
Q1 		$30K Buy
+945
New +$27.1K ﹤0.01% 1869

Other funds holding AXTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geneos Wealth Management's AXTA Position: Q3 2025 in Review

Geneos Wealth Management sold out of Axalta (AXTA) in Q3 2025, closing a stake of 446 shares — an estimated $13.2K sold.

Geneos Wealth Management first reported a position in AXTA in Q1 2021 and held it in 5 quarters. The position peaked at $30K in Q1 2021. 392 funds tracked by Wall St. Rank hold AXTA as of Q3 2025.

  • Geneos Wealth Management reported no remaining Axalta position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 446 Axalta shares in Q3 2025, an estimated $13.2K.
  • Geneos Wealth Management first reported a position in Axalta in Q1 2021 and held it in 5 quarters.
  • Geneos Wealth Management's Axalta position peaked at $30K in Q1 2021.
  • 392 funds tracked by Wall St. Rank held Axalta as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.